Page last updated: 2024-11-04

sulfasalazine and Emesis

sulfasalazine has been researched along with Emesis in 11 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
" The frequency and nature of adverse effects and changes in clinical and laboratory parameters of disease activity were measured after three and six months."2.68Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis. ( Capell, HA; Hunter, JA; Madhok, R; McInnes, IB; Murphy, EA; Porter, D; Pullar, T; Thomson, EA, 1996)
"Seventeen patients with ulcerative colitis and three patients with Crohn's disease exhibited different side effects during sulfasalazine therapy."1.26Desensitization of patients with inflammatory bowel disease to sulfasalazine. ( Das, KM; Taffet, SL, 1982)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19906 (54.55)18.7374
1990's3 (27.27)18.2507
2000's1 (9.09)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoversten, P1
Beachey, J1
Pham, M1
Bhagra, A1
Shenoy, P1
Misra, R1
Jain, M1
Agarwal, V1
Taffet, SL1
Das, KM2
McInnes, IB1
Porter, D1
Murphy, EA1
Thomson, EA1
Madhok, R1
Hunter, JA2
Pullar, T2
Capell, HA2
Huang, JL1
Chen, LC1
Isaza, R1
Baker, B1
Dunker, F1
Korelitz, BI1
Glass, JL1
Wisch, N1
Eastwood, MA1
McManus, JP1
Sircus, W1
Kater, F1
Collins, JR1

Trials

2 trials available for sulfasalazine and Emesis

ArticleYear
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    Annals of the rheumatic diseases, 1996, Volume: 55, Issue:5

    Topics: Anorexia; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Administration Sche

1996
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    British journal of rheumatology, 1985, Volume: 24, Issue:3

    Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Sedimentation; Clinical Trials as Topic; Dose-Response Rel

1985

Other Studies

9 other studies available for sulfasalazine and Emesis

ArticleYear
A rare cause of oligoarthritis with septic presentation.
    BMJ case reports, 2018, Apr-17, Volume: 2018

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Diarrhea; Dysuria; Fever; Gastr

2018
Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.
    The New Zealand medical journal, 2008, Jun-20, Volume: 121, Issue:1276

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Drug Eruptions; Drug Hy

2008
Desensitization of patients with inflammatory bowel disease to sulfasalazine.
    The American journal of medicine, 1982, Volume: 73, Issue:4

    Topics: Colitis, Ulcerative; Crohn Disease; Desensitization, Immunologic; Dose-Response Relationship, Drug;

1982
Sulphasalazine in the treatment of children with chronic arthritis.
    Clinical rheumatology, 1998, Volume: 17, Issue:5

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Clinical Trials as T

1998
Medical management of inflammatory bowel disease in a spider monkey.
    Journal of the American Veterinary Medical Association, 1992, May-15, Volume: 200, Issue:10

    Topics: Animals; Cebidae; Diarrhea; Electrolytes; Female; Inflammatory Bowel Diseases; Monkey Diseases; Pred

1992
Long-term immunosuppressive therapy of ulcerative colitis. Continuation of a personal series.
    The American journal of digestive diseases, 1973, Volume: 18, Issue:4

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Child; Child, Preschool; Colitis, Ulcerative; Female

1973
Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.
    The New England journal of medicine, 1973, Sep-06, Volume: 289, Issue:10

    Topics: Acetylation; Agranulocytosis; Aminosalicylic Acids; Anemia, Hemolytic; Colitis, Ulcerative; Crohn Di

1973
[Hemolysis, formation of Heinz bodies and of methemoglobin under therapy with Azulfidine (author's transl)].
    Medizinische Klinik, 1974, Mar-15, Volume: 69, Issue:11

    Topics: Adult; Colitis, Ulcerative; Cyanosis; Diarrhea; Erythrocytes; Female; Headache; Heinz Bodies; Hemato

1974
Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.
    Southern medical journal, 1968, Volume: 61, Issue:4

    Topics: Adult; Agranulocytosis; Colitis, Ulcerative; Dermatitis; Exanthema; Headache; Hematologic Diseases;

1968